BENCHMARK I
PART 3
1)
Biological
Agents.
Bacteria: .
Anthrax
. Bubonic Plague
. Cholera
. Tularemia
. Pneumonic Plague . Q Fever
Virus: . Smallpox
. Venezuelan Equine
Encephalitis
. Viral Hemorrhagic
Fevers
Toxin:
. Botulinum
. Staphylococcal
Enterotoxin B
. Saxitoxin
. Ricin
. Mycotoxins
Anthrax
is a zoonotic disease caused by Bacillus anthracis. There are two types of this disease: cutaneous
anthrax and inhalation anthrax.
Cutaneous anthrax develops when a bacterial organism from infected
animal tissues becomes deposited under the skin.
The disease begins after an incubation
period varying from 1-6 days.
Inhalation anthrax develops when the bacterial
organism is inhaled into the lungs. A progressive infection follows.
A
lethal dose of anthrax is considered to be 10,000 spores; 80 percent of a
population that inhaled such a dose would die. Less than one millionth of a
gram is invariably fatal within five days to a week after exposure.
The
initial symptoms are followed in 2-3 days by the abrupt development of severe
respiratory distress with dyspnea, diaphoresis, strider, and cyanosis. Physical
findings may include evidence of pleural effusions, edema of the chest wall,
and meningitis. Chest x-ray reveals a dramatically widened mediastinum, often
with pleural effusions, but typically without infiltrates. Shock and death
usually follow within 24-36 hours of respiratory distress onset.
A biological warfare attack with anthrax spores
delivered by aerosol would cause inhalation anthrax, an extraordinarily rare
form of the naturally occurring disease.
Botulism
is caused by intoxication with the any of the seven distinct neurotoxins
produced by the bacillus, Clostridium botulinum. The toxins are proteins with molecular weights
of approximately 150,000, which bind to the presynaptic membrane of neurons at
peripheral cholinergic synapses to prevent release of acetylcholine and block
neurotransmission.
Symptoms
of inhalation botulism may begin as early as 24-36 hours following exposure or
as late as several days. Initial signs and symptoms include ptosis, generalized
weakness, lassitude, and dizziness. Diminished salivation with extreme dryness
of the mouth and throat may cause complaints of a sore throat. Urinary
retention or ileus may also occur. Motor symptoms usually are present early in
the disease; cranial nerves are affected first with blurred vision, diplopia,
ptosis, and photophobia. Development of respiratory failure may be abrupt.
Mucous membranes of the mouth may be dry and crusted. Neurological examination
shows flaccid muscle weakness of the palate, tongue, larynx, respiratory
muscles, and extremities. Deep tendon reflexes vary from intact to absent.
Respiratory
failure secondary to paralysis of respiratory muscles is the most serious
complication and, generally, the cause of death.
Brucellosis
is a systemic zoonotic disease caused by one of four species of bacteria: Brucella
melitensis, B. abortus, B. suis, and B. canis; virulence for humans decreases somewhat in the
order given. These bacteria are small gram-negative, aerobic, non-motile
coccobacilli that grow within monocytes and macrophages. Their natural
reservoir is domestic animals, such as goats, sheep, and camels (B.
melitensis); cattle (B.
abortus); and pigs (B.
suis). Brucella canis is primarily a pathogen of dogs, and only
occasionally causes disease in humans. Humans are infected when they inhale
contaminated aerosols, ingest raw (unpasteurized) infected milk or meat, or
have abraded skin or conjunctival surfaces that come in contact with the
bacteria.
Brucellosis
presents after an incubation period normally ranging from 3-4 weeks, but may be
as short as 1 week or as long as several months. Clinical disease presents
typically as an acute, non-specific febrile illness with chills, sweats,
headache, fatigue, myalgias, arthralgias, and anorexia. Cough occurs in 15-25%,
but the chest x-ray usually is normal. (Complications include sacroiliitis,
arthritis, vertebral osteomyelitis, epididymo-orchitis, and rarely
endocarditis. Physical findings include Iymphadenopathy in 10-20% and
splenomegaly in 20-30% of cases). Brucellosis may be indistinguishable
clinically from the typhoidal form of tularemia or from typhoid fever itself.
The disease in humans is characterized by a multitud e of somatic complaints,
including fever, sweats, anorexia, fatigue, malaise, weight loss, and
depression.
Cholera. Cholera
is a diarrheal disease caused by Vibrio cholera, a short, curved, gram-negative bacillus.
Humans acquire the disease by consuming water or food contaminated with the
organism. The organism multiplies in the small intestine and secretes an
enterotoxin that causes a secretory diarrhea. Without treatment, death may result from severe dehydration,
hypovole mia and shock. Vomiting is often present early in the illness and may
complicate oral replacement of fluid losses. There is little or no fever or
abdominal pain.
Watery
diarrhea can also be caused by enterotoxigenic E. coli, rotavirus or other viruses, noncholera vibrios, or food poisoning due to ingestion of
preformed toxins such as those of Clostridium perfringens, Bacillus cereus, or Staphylococcus aureus.
Clostridium
perfringens is a common
anaerobic bacterium associated with three distinct disease syndromes; gas
gangrene or clostridial myonecrosis; enteritis necroticans (pig-bel); and
clostridium food poisoning.
It is difficult to imagine a general
scenario in which the spores or vegetative organisms could be used as a
biological warfare agent. There are, however, at least 12 protein toxins
elaborated, and one or more of these could be produced, concentrated, and used
as a weapon. Waterborne disease is conceivable, but unlikely. The alpha toxin
would be lethal by aerosol. This is a well characterized, highly toxic
phospholipase C. Other
toxins from the organism might be co-weaponized and enhance effectiveness.
Gas
gangrene is a well-recognized, life-threatening emergency. Symptoms of the
disease may be subtle before fulminant toxemia develops, and the diagnosis is
often made at postmortem examination. The bacteria produce toxins that create
the high mortality from clostridial myonecrosis, and which produce the
characteristic intense pain out of proportion to the wound. Within hours signs
of systemic toxicity appear, including confusion, tachycardia, and sweating.
It
is difficult to imagine a general scenario in which the spores or vegetative
organisms could be used as a biological warfare agent. There are, however, at
least 12 protein toxins elaborated, and one or more of these could be produced,
concentrated, and used as a weapon. Waterborne disease is conceivable, but
unlikely. The alpha toxin would be lethal by aerosol. This is a well
characterized, highly toxic phospholipase C. Other toxins from the organism
might be co-weaponized and enhance effectiveness.
Congo-Crimean Hemorrhagic Fever. Congo-Crimean
hemorrhagic fever (CCHF) is a viral disease caused by CCHF virus. The virus,
first isolated in Congo, next found in the Crimea, occurs also in the Middle
East, the Balkans, the former USSR, and eastern China.
Little is known about variations in the
virus properties over the huge geographic area involved. Humans become infected
through tick bites, crushing an infected tick, or at the slaughter of viremic
livestock. Even in epidemics, cases do not show narrow clustering and
person-to-person spread is rare.
Following infection via tick bite, the incubation period is
usually one to three days, with a maximum of nine days. The incubation period
following contact with infected blood or tissues is usually five to six days,
with a documented maximum of 13 days. There is severe headache, lumbar pain,
nausea and vomiting, delirium, and prostration. Fatal cases are associated with
extensive hemorrhage, coma, and shock.
Convalescence
in survivors is prolonged with asthenia, dizziness, and often hair loss.
Patients
with suspected or confirmed CCHF should be isolated and cared for using barrier
nursing techniques.
The
virus is aerosol-infectious and additional precautions (for example,
respirators) might be considered in a biological warfare setting.
CCHF
would probably be delivered by aerosol if used as a BW agent.
Ebola
Haemorrhagic Fever is one of the most virulent viral diseases known to
humankind, causing death in 50-90% of all clinical cases.
The disease has its origins in the jungles of Africa and Asia and several different forms of Ebola virus have been identified and may be associated with other clinical expressions, on which further research is required.
The
Ebola virus is transmitted by direct contact with the blood, secretions, organs
or semen of infected persons. Transmission through semen may occur up to 7
weeks after clinical recovery, as with Marburg Haemorrhagic fever.
After
an incubation period of 2 to 21 days, Ebola is often characterised by the sudden
onset of fever, weakness, muscle pain, headache and sore throat. This is
followed by vomiting, diarrhoea, rash, limited kidney and liver functions, and
both internal and external bleeding
Suspected
cases should be isolated from other patients and strict barrier nursing
techniques practised. All hospital personnel should be briefed on the nature of
the disease and its routes of transmission.
Hospital staff should have individual
gowns, gloves and masks. Gloves and masks must not be reused unless disinfected.
Patients who die from the disease should be promptly buried or cremated.
Consequently,
it has figured prominently in popular discussions of biological warfare.
As
a biological warfare agent remain speculative.
Melioidosis
is an infectious disease of humans and animals caused by Pseudomonas
pseudomallei, a gram-negative
bacillus. It is especially prevalent in Southeast Asia but has been described
from many countries around the world.
Infection
by inoculation results in a subcutaneous nodule with acute lymphangitis and
regional lymphadenitis, generally with fever. Pneumonia may occur after
inhalation or hematogenous dissemination of infection. It may vary in intensity
from mild to fulminant, usually involves the upper lobes, and often results in
cavitation. Pleural effusions are uncommon. An acute fulminant septicemia may
occur characterized by rapid appearance of hypotension and shock. A chronic
suppurative form may involve virtually any organ in the body.
A
biological warfare attack with this organism would most likely be by the
aerosol route.
Plague.
Plague
is a zoonotic disease caused by Yersinia pestis. Under natural conditions, humans become
infected as a result of contact with rodents, and their fleas. The transmission
of the gram-negative coccobacillus is by the bite of the infected flea, Xenopsylla
cheopis, the oriental rat
flea, or Pulex irritans, the
human flea. Under natural conditions, three syndromes are recognized: bubonic,
primary septicemia, or pneumonic. In bubonic plague, the incubation period
ranges from 2 to 10 days. The onset is acute and often fulminant with malaise,
high fever, and one or more tender lymph nodes. Inguinal lymphadenitis (bubo)
predominates, but cervical and axillary lymph nodes c an also be involved. The
involved nodes are tender, fluctuant, and necrotic. Bubonic plague may progress
spontaneously to the septicemia form with organisms spread to the central
nervous system, lungs (producing pneumonic disease), and elsewhere. The
mortality is 50 percent in untreated patients with the terminal event being
circulatory collapse, hemorrhage, and peripheral thrombosis.
o In primary pneumonic plague, the incubation
period is 2 to 3 days. The onset is acute and fulminant with malaise, high
fever, chills, headache, myalgia, cough with production of a bloody sputum, and
toxemia. The pneumonia progresses rapidly, resulting in dyspnea, strider, and
cyanosis. In untreated patients, the mortality is 100 percent with the terminal
event being respiratory failure, circulatory collapse, and a bleeding
diathesis.
Plague
may be spread from person to person by droplets. Strict isolation procedures
for all cases are indicated
In
a biological warfare scenario, the plague bacillus could be delivered via
contaminated vectors (fleas) causing the bubonic type or, more likely, via
aerosol causing the pneumonic type.
Q
fever is a zoonotic disease caused by a rickettsia, Coxiella burnetii. The most common animal reservoirs are sheep,
cattle and goats. Humans acquire the disease by inhalation of particles
contaminated with the organisms. A biological warfare attack would cause
disease similar to that occurring naturally.
Following
an incubation period of 10-20 days, Q fever generally occurs as a self-limiting
febrile illness lasting 2 days to 2 weeks. Pneumonia occurs frequently, usually
manifested only by an abnormal chest x-ray. A nonproductive cough and pleuritic
chest pain occur in about one-fourth of patients with Q fever pneumonia.
Patients usually recover uneventfully.
Q
fever usually presents as an undifferentiated febrile illness, or a primary
atypical pneumonia, which must be differentiated from pneumonia caused by
mycoplasma, legionnaire's disease, psittacosis or Chlamydia pneumonia. More rapidly progressive forms of pneumonia
may look like bacterial pneumonias including tularemia or plague.
A
biological warfare attack would cause disease similar to that occurring
naturally.
Ricin
is a glycoprotein toxin (66,000 daltons) from the seed of the castor plant. It
blocks protein synthesis by altering the rRNA, thus killing the cell.
All
reported serious or fatal cases of castor bean ingestion have taken
approximately the same course: rapid onset of nausea, vomiting, abdominal
cramps and severe diarrhea with vascular collapse; death has occurred on the
third day or later. Following inhalation, one might expect nonspecific symptoms
of weakness, fever, cough, and hypothermia followed by hypotension and
cardiovascular collapse. The exact cause of death is unknown and probably
varies with route of intoxication. High doses by inhalation appear to produce
severe enough pulmonary damage to cause death.
Ricin's
significance as a potential biological warfare agent relates to its
availability world wide, its ease of production, and extreme pulmonary toxicity
when inhaled.
Rift
Valley Fever (RVF) is a viral disease caused by RVF virus. The virus circulates
in sub-Saharan Africa as a mosquito-borne agent. Epizootics occur when
susceptible domestic animals are infected, and because of the large amount of
virus in their serum, amplify infection to biting arthropods. Deaths and
abortions among susceptible species such as cattle and sheep constitute a major
economic consequence of these epizootics, as well as providing a diagnostic
clue and a method of surveillance. Humans become infected by the bite of
mosquitoes or by exposure to virus-laden aerosols or droplets. The human
disease appears to be similar whether acquired by aerosol or by mosquito bite.
The
incubation is two to five days and is usually followed by an incapacitating
febrile illness of similar duration. The typical physical findings are fever,
conjunctival injection, and sometimes-abdominal tenderness. A small proportion
of cases (approximately one percent) will progress to a viral hemorrhagic fever
syndrome; mortality in this group is roughly 50 percent. A small number of
infections will lead to a late encephalitis. After apparent recovery from a
typical febrile illness, the patient develops fever, meningeal signs,
obtundation, and focal defects. These patients may die or often have serious
sequelae.
The
occurrence of an epidemic with febrile disease, hemorrhagic fever, eye lesions,
and encephalitis in different patients would be characteristic of RVF.
Demonstration of viral antigen in blood by ELISA is rapid and successful in a
high proportion of acute cases of uncomplicated disease or hemorrhagic fever.
Saxitoxin
is the parent compound of a family of chemically related neurotoxins. In nature
they are predominantly produced by marine dinoflagellates, although they have
also been identified in association with such diverse organisms as blue-green
algae, crabs, and the blue-ringed octopus. Human intoxications are principally
due to ingestion of bivalve molluscs, which have accumulated dinoflagellates
during filter feeding. The resulting intoxication, known as paralytic shellfish
poisoning (PSP), is known throughout the world as a severe, life-threatening
illness requiring immediate medical intervention.
Onset
of symptoms typically begins 10-60 minutes after exposure, but may be delayed
several hours depending upon the dose and individual idiosyncrasy. Initial
symptoms are numbness or tingling of the lips, tongue and fingertips, followed
by numbness of the neck and extremities and general muscular incoordination.
Respiratory distress and flaccid muscular paralysis are the terminal stages and
can occur 2-12 hours after intoxication. Death results from respiratory
paralysis.
Smallpox virus, an orthopoxvirus with a narrow
host range confined to humans, was an important cause of morbidity and
mortality in the developing world until recent times. Eradication of the
natural disease was completed in 1977 and the last human case s (laboratory
infections) occurred in 1978. Under natural conditions, t he virus is
transmitted by direct (face-to face) contact with an infected case, by fomites,
and occasionally by aerosols. Smallpox virus is highly stable and retains
infectivity for long periods outside of the host. A related virus, monkeypox,
clinically resembles smallpox and causes sporadic human disease in West and
Central Africa.

The
incubation period is typically 12 days (range, 10-17 days). The illness begins
with a prodrome lasting 2-3 days, with generalized malaise, fever, rigors,
headache, and backache. This is followed by defervescence and the appearance of
a typical skin eruption characterized by progression over 7-10 days of lesions
through successive stages, from macules to papules to vesicles to pustules. The
latter finally form crusts and, upon healing, leave depressed depigmented
scars. The case fatality rate is app roximately 35% in unvaccinated individuals
Staphylococcal
Enterotoxin B (SEB) is one of several exotoxins produced by Staphylococcus
aureus, causing food poisoning
when ingested.
The
disease begins 1-6 hours after exposure with the sudden onset of fever, chills,
headache, myalgia, and nonproductive cough. In more severe cases, dyspnea and
retrosternal chest pain may also be present. Fever, which may reach 103-106¡ F,
has lasted 2-5 days, but cough may persist 1-4 weeks. In many patients nausea,
vomiting, and diarrhea will also occur.
In
foodborne SEB intoxication, fever and respiratory involvement are not seen, and
gastrointestinal symptoms are prominent. The nonspecific findings of fever,
nonproductive cough, myalgia, and headache occurring in large numbers of
patients in an epide mic setting would suggest any of several infectious
respiratory pathogens, particularly influenza, adenovirus, or mycoplasma.
A
BW attack with aerosol delivery of SEB to the respiratory tract produces a
distinct syndrome causing significant morbidity and potential mortality.
In
a BW attack with SEB, cases would likely have their onset within a single day,
while naturally occurring outbreaks would prese nt over a more prolonged
interval.
The
trichothecene mycotoxins are a diverse group of more than 40 compounds produced
by fungi. They are potent inhibitors of protein synthesis, impair DNA
synthesis, alter cell membrane structure and function, and inhibit
mitochondrial respiration. Naturally occurring trichothecenes have been
identified in agricultu ral products and have been implicated in a disease of
animals known as moldy corn toxicosis or poisoning.
Consumption
of these mycotoxins results in weight loss, vomiting, skin inflammation, bloody
diarrhea, diffuse hemorrhage, and possibly death. The onset of illness
following acute exposure to T-2 (IV or inhalation) occurs in hours, resulting
in the rapi d onset of circulatory shock characterized by reduced cardiac
output, arterial hypotension, lactic acidosis and death within 12 hours.
Clinical
signs and symptoms of ATA were hemorrhage, leukopenia, ulcerative pharyngitis,
and depletion of bone marrow. The purported use of T-2 as a BW agent resulted
in an acute exposure via inhalation and/or dermal routes, as well as oral
exposure upo n consumption of contaminated food products and water. Alleged
victims reported painful skin lesions, lightheadedness, dyspnea, and a rapid
onset of hemomhage, incapacitation and death. Survivors developed a
radiation-like sickness including fever, nausea , vomiting, diarrhea,
leukopenia, bleeding, and sepsis.
There
are no well-documented cases of clinical exposure of humans to trichothecenes.
However, strong circumstantial evidence has associated these toxins with alimentary
toxic aleukia (ATA), the fatal epidemic seen in Russia during World War II, and
with alleged BW incidents ("yellow rain") in Cambodia, Laos and
Afghanistan.
Tularemia
is a zoonotic disease caused by Francisella tularensis, a gram-negative bacillus. Humans acquire the
disease under natural conditions through inoculation of skin or mucous
membranes with blood or tissue fluids of infected animals, or bites of infected
deerflies, mosquitoes, or ticks.
A
variety of clinical forms of tularemia are seen, depending upon the route of
inoculation and virulence of the strain. In humans, as few as 10-50 organisms
will cause disease if inhaled or injected intradermally, whereas 108
organisms are required with oral challenge. Under natural conditions, ulceroglandular
tularemia generally occurs about 3 days after intradermal inoculation (range
2-10 days), and manifests as regional lymphadenopathy, fever, chills, headache,
and malaise, with or without a cutaneous ulcer.
Pneumonic
tularemia is a severe atypical
pneumonia that may be fulmi nant, and can be primary or secondary. Primary
pneumonia may follow direct inhalation of infectious aerosols, or may result
from aspiration of organisms in cases of pharyngeal tularemia.
Pneumonic tularemia causes fever,
headache, malaise, substernal disc omfort, and a non-productive cough;
radiologic evidence of pneumonia or mediastinal lymphadenopathy may or may not
be present.
A
biological warfare attack with F. tularensis would most likely be delivered by
aerosol, causing primarily typhoidal tularemia.
A
BW attack with F. tularensis delivered by aerosol would primarily cause
typhoidal tularemia, a syndrome expected to have a case fatality rate which may
be higher than the 5-10% seen when dise ase is acquired naturally.
A clue to the diagnosis of tularem ia
delivered as a BW agent might be a large number of temporally clustered
patients presenting with similar systemic illnesses, a proportion of whom will
have a nonproductive pneumonia
Eight
serologically distinct viruses belonging to the Venezuelan equine encephalitis
(VEE) complex have been associated with human disease; the most important of
these pathogens are designated subtype 1, variants A, B and C. These agents
also cause severe disease in horses, mules, and donkeys (Equidae). Natural
infections are acquired by the bites of a wide variety of mosquitoes.
Nearly
100% of those infected suffer an overt illness. After an incubation period of
1-5 days, onset of illness is extremely sudden, with generalized malaise,
spiking fever, rigors, severe headache, photophobia, myalgia in the legs and
lumbosacral area. Nausea, vomiting, cough, sore throat, and diarrhea may
follow. This acute phase lasts 24-72 hours. A prolonged period of aesthenia and
lethargy may follow, with full health and activity regained only after 1-2
weeks. Approximately 4% of patients during natural epidemics develop signs of
central nervous system infection, with meningismus, convulsions, coma, and
paralysis. These necrologic cases are seen almost exclusively in children. The
overall case-fatality rate is <1%, but in children with encephalitis, it may
reach 20%.
A
BW attack with virus disseminated as an aerosol would cause human disease as a
primary event. If Equidae were present, disease in these animals would occur
simultaneously with human disease. Secondary spread by person-to-person\contact
occurs at a negligible rate. However, a BW attack in a region populated by
Equidae and appropriate mosquito vectors could initiate an epizootic/epidemic.
![]()
A Historical
Example of the Use of Biological Weapons
An early instance of the use of biological agents in warfare occurred
during a battle at the seaport of Caffa on
the Black Sea in 1346 to 1347 in which the Tatars catapulted corpses infected
with plague into the city in order to infect the Genoese sailors inside.
The story of the
British giving blankets contaminated with smallpox in order to infect Native Americans during the French and Indian Wars (1
754-1767) is another early case of the use of biological agents in warfare.
In World War I, German secret agents even tried to infect Allied horses and cattle destined for
the front with the bacterial diseases anthrax and
glanders and in the period before and during the Second World War, Japanese
scientists experimented with biological warfare at their infamous Unit 731 in
China.
The Ebola virus was first identified in a
western equatorial province of Sudan and in a nearby region of Zaire in 1976
after significant epidemics in Yamkubu, northern Zaire, and Nzara, southern
Sudan. Between June and November 1976 the Ebola virus infected 284 people in
Sudan, with 117 deaths. In Zaire there were 318 cases and 280 deaths in
September and October. An isolated case occurred in Zaire in 1977, a second
outbreak in Sudan in 1979. In 1989 and 1990, a filovirus, named Ebola-Reston,
was isola ted in monkeys being held in quarantine in a laboratory in Reston
(Virginia), Alice (Texas) and Pennsylvania. In the Philippines, Ebola-Reston
infections occurred in the quarantine area for monkeys intended for
exportation, near Manila. A large epidemic o ccurred in Kikwit, Zaire in 1995
with 315 cases, 244 with fatal outcomes. One human case of Ebola haemorrhagic
fever and several cases in chimpanzees were confirmed in Cфte d'Ivoire in 1994-95. In Gabon, Ebola
haemorrhagic fever was first documented in 19 94 and recent outbreaks occurred
in February 1996 and July 1996. In all, nearly 1,100 cases with 793 deaths have
been documented since the virus was discovered. The natural reservoir of the
Ebola virus seems to reside in the rain forests of Africa and Asia but has not
yet been identified.